Haisco Pharmaceutical Group News

Haisco Pharmaceutical Group: 002653 Haisco Pharmaceutical Group Investor Relations Management Information 20240816

Aug 16 16:44

Haisco Pharmaceutical Group: Company Bylaws (August 2024)

Aug 16 00:00

Haisco Pharmaceutical Group: Special report on the use of funds raised during the first half of 2024.

Aug 16 00:00

Haisco Pharmaceutical Group: Announcement of the resolution of the Supervisory Board on the semi-annual report.

Aug 16 00:00

Haisco Pharmaceutical Group: Announcement of Board of Directors' resolution for semi-annual report.

Aug 16 00:00

Haisco Pharmaceutical Group: Announcement of the resolution of the 16th meeting of the 5th Board of Directors.

Aug 15 00:00

Haisco Pharmaceutical Group: Announcement of Resolutions of the Seventh Meeting of the Fifth Supervisory Committee.

Aug 15 00:00

Haisco Pharmaceutical Group: Management Measures for the Implementation of Restricted Stock Incentive Plan Assessment in 2024.

Aug 15 00:00

Haisco Pharmaceutical Group: Announcement Regarding Obtaining the Drug Clinical Trial Approval Notice for Innovative Drug HSK44459 Tablets

Aug 8 00:00

Haisco Pharmaceutical Group: Announcement regarding obtaining the clinical trial approval notice for the innovative drug HSK39004 inhalation suspension.

Jul 26 00:00

Haisco Pharmaceutical Group: Announcement on obtaining new indications for Type 1 innovative drug Cligabalin Hydrochloride Capsules in the Drug Registration Certificate

Jul 8 00:00

Haisco Pharmaceutical Group: Announcement of the resolution of the 15th meeting of the 5th board of directors.

Jun 28 00:00

Haisco Pharmaceutical Group: Announcement Regarding Obtaining the Pharmaceutical Registration Certificate for Class 1 Innovative Drug - Carvedilol Tablets

Jun 25 11:44

Haisco Pharmaceutical Group: Announcement regarding the approval notice for clinical trial of innovative drug HSK42360 tablets.

Jun 13 00:00

Haisco Pharmaceutical Group: Notice on Obtaining the “Drug Registration Certificate” for Class 1 Innovative Drug Cligabarin Benzenesulfonate Capsules

May 21 11:46

Haisco Pharmaceutical Group: 002653 HiCisco Investor Relations Management Information 20240510

May 10 16:38

Haisco Pharmaceutical Group: Announcement on holding the 2023 online results briefing

May 7 00:00

Haisco Pharmaceutical Group: Announcement of Resolutions of the 14th Meeting of the Fifth Board of Directors

Apr 30 11:49

Haisco Pharmaceutical Group: Articles of Association (April 2024)

Apr 30 11:49

Haisco Pharmaceutical Group: Announcement of Resolutions of the Sixth Meeting of the Fifth Board of Supervisors

Apr 30 11:49